MHRA Admits Their Circular Reasoning. Flu Vaccine 42% Effective & RSV Vaccine Linked to GBS

March 13, 2024

https://expose-news.com/2024/03/12/mhra-admits-using-circular-reasoning/

MHRA admits using circular reasoning in claiming huge number of covid vaccine injuries reported are due to “high public awareness”

BY RHODA WILSON ON 

The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has acknowledged that it used circular reasoning and lacks documentation to support its explanation why there is a high number of Yellow Card reports related to covid injections. The agency asserted that the increase in reports is due to heightened public awareness, resulting in more people submitting reports than usual.  (See link for article)

________________

**Comment**

The UK’s MHRA Yellow Card scheme is similar to the  U.S. VAERS system where people can voluntarily report any suspected adverse reactions to vaccines.  Similarly to the staggering amount of adverse reactions and death being reported to VAERS after the COVID gene therapy injections, there is also an unprecedented uptick in Yellow Card reports.  Both have an abysmal capture rate.

But rather than simply admit the obvious, ‘the powers that be’ continue the #ABV narrative (anything but the ‘vaccine’) which is blaming heightened public awareness for the surge in reports despite ZERO data to support its claim.

https://thevaccinereaction.org/2024/03/influenza-vaccines-only-42-percent-effective-in-adults-this-year/

Influenza Vaccines Only 42 Percent Effective in Adults This Year

by Marco Cáceres

Published 

Article Excerpts:

The influenza vaccines currently being administered in the United States are estimated by the U.S. Centers for Disease Control and Prevention (CDC) to be 42 percent effective in adults. This is an interim estimate for the 2023-2024 “flu season” published in the agency’s Morbidity and Mortality Weekly Report (MMWR) on Feb. 29, 2024.1 2 3

By “effective,” the CDC is referring to reducing the risk of influenza-related hospitalizations or “medically attended influenza virus infection, not actually preventing influenza infections—notably influenza A (H1N1) and B (Victoria lineage).1

Most influenza-like-illness (ILI) which occurs during the “flu season” is not actually caused by  type A or type B influenza. Studies show that less than 25 percent of suspected ILI cases turn out to be influenza after lab testing. There are many other respiratory infections that look like influenza but are caused by other types of viruses and bacteria.2.4

There are nine influenza vaccines that are licensed by the U.S. Food and Drug Administration (FDA) for distribution during the 2023-2024 flu season, each of which contains at least one ingredient that is a potential allergen.

  • Alfuria contains the mercury-based preservative thimerosal (multiple-dose vials), egg protein, neomycin and polymyxin.
  • Fluad contains egg protein, kanamycin, neomycin and polysorbate 80.
  • Fluarix contains egg protein, gentamicin and polysorbate 80.
  • Flublok contains polysorbate 20.
  • Flucelvax contains thimerosal (multiple-dose vials) and polysorbate 80.
  • FluLaval contains egg protein and polysorbate 80.
  • FluMist contains egg protein, gentamicin, pork gelatin and monosodium glutamate (MSG).
  • Fluzone contains egg protein.
  • Fluzone High-Dose contains thimerosal (multiple-dose vials) and egg protein.9

https://thevaccinereaction.org/2024/03/rsv-vaccines-for-senior-adults-linked-to-guillain-barre-syndrome/

RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome

by Rishma Parpia

Published 

Excerpts:

On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or vaccination, the body attacks the peripheral nerves. GBS symptoms begin with muscle weakness and numbness or tingling in different parts of the body and recovery can be complete or paralysis of one or more limbs can occur, including full body paralysis, which can lead to death.2

The CDC’s analysis evaluated preliminary rates of GBS following one dose of either GSK plc’s RSVPreF3+AS01 (AREXVY) vaccine or Pfizer, Inc.’s RSVPreF (ABRYSVO) vaccine and compared it to the rates of GBS in an historical control group.

Data from the U.S. Food and Drug Administration (FDA) also illustrated a higher- than-expected number of GBS cases being reported in RSV vaccine recipients. Tom Shimabukuro, MD, director of the Immunization Safety Office at the CDC said:

Taken together, these data suggest a potential increased risk [of GBS after RSV vaccinations].6

 For more:

Category:

Activism, vaccines

Comments Off on MHRA Admits Their Circular Reasoning. Flu Vaccine 42% Effective & RSV Vaccine Linked to GBS